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Background: Despite advancements in wound healing techniques and devices, new treatments are needed to
improve therapeutic outcomes. This study aimed to evaluate the potential use of a new biomaterial engineered
from human urine-derived stem cells (USCs) and polycaprolactone/gelatin (PCL/GT) for wound healing.
Methods: USCs were isolated from healthy individuals. To fabricate PCL/GT composite meshes, twin-nozzle electrospinning
were used to spin the PCL and gelatin solutions in normal organic solvents. The morphologies and hydrophilicity properties
of PCL/GT membranes were investigated. After USCs were seeded onto a PCL/GT, cell adhesion, morphology, proliferation,
and cytotoxicity were examined. Then, USCs were seeded on a PCL/GT blend nanofibrous membrane and transplanted into
rabbit full-thickness skin defects for wound repair. Finally, the effect of USCs condition medium on proliferation, migration,
and tube formation of human umbilical vein endothelial cells (HUVECs) were performed in vitro.
Results: USCs were successfully isolated from urine samples and expressed specific mesenchymal stem cells markers and
could differentiate into osteoblasts, adipocytes, and chondrocytes. PCL/GT membrane has suitable mechanical properties
similar with skin tissue and has good biocompatibility. USCs-PCL/GT significantly enhanced the healing of full-thickness skin
wounds in rabbits compared to wounds treated with PCL/GT membrane alone or untreated wounds. USCs-PCL/GT-treated
wounds closed much faster, with increased re-epithelialization, collagen formation, and angiogenesis. Moreover, USCs could
secrete VEGF and TGF-β1, and USC-conditioned medium enhanced the migration, proliferation, and tube formation of
endothelial cells.
Conclusion: USCs in combination with PCL/GT significantly prompted the healing of full-thickness skin wounds in rabbits.
USCs based therapy provides a novel strategy for accelerating wound closure and promoting angiogenesis.
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Autologous, allograft, and xenograft skin transplants are
often employed to treat large areas of skin damage caused
by wounds, ulcers, burns, or inflammation. However, au-
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unless otherwise stated.are limited by the risk of immune rejection or infectious
disease; thus, meeting the needs of clinical applications is
difficult [1-3]. Tissue engineered skin has recently become
a promising strategy for treating large skin defects and
skin ulcers that are difficult to heal [4-6], and stem cells
have shown unique advantages for the construction of
engineered skin tissue. Adipose-derived mesenchymal
stem cells (ASCs) seeded in sodium carboxymethyl cellu-
lose (CMC) promoted wound healing in rats [7]. ASCs
seeded in a composite elastic protein electrostatic nanofi-
ber also effectively promoted mouse wound healing [8].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ited by the source and by invasive routes of collection and
embryonic stem cells or induced pluripotent stem cells
have issues with respect to ethics, immune rejection,
tumorigenicity, and other areas. Therefore, the identifi-
cation of a new source of autologous stem cells that is
easy to obtain via a non-invasive route is imperative.
Recently, stem-like cells have been extracted from
adult urine and named urine derived stem cells (USCs)
[9-12]. These cells exhibit stem cell markers similar to
those of ASCs and the ability to differentiate into osteo-
cytes, chondrocytes, adipocytes, and endothelial cells
[12]. USCs have been studied as an alternative to cell
therapy and tissue engineering for urological applica-
tions during the treatment of stress urinary incontinence
and vesicoureteral reflux and during bladder and urethra
tissue engineering [10,11,13] and nerve damage repair
[14]. However, the application of USCs to skin tissue en-
gineering has not been reported.
The identification of appropriate scaffold materials for
skin tissue engineering is a challenge. The application of
stem cells in combination with biomaterials plays an in-
creasingly prominent role in tissue engineering and re-
generative medicine [15]. An appropriate tissue scaffold
should confer mechanical properties and good biocom-
patibility for wound healing [16]. A large fraction of
electrospun nanofibrous mesh exists in the form of in-
terconnected porosity [17-19]. Compared to regular fibers,
these nanofibers have a higher-specific surface area, a
higher aspect ratio, and higher porosity; these characteris-
tics give the mats strong absorbability, good filtration, ef-
fective seclusion, and high conglutinating quality, providing
good accommodation for the cells and easy passage for nu-
trient intake and metabolic waste exchange. A large num-
ber of electrospun meshes have been used for wound
regeneration, particularly polycaprolactone (PCL)-based
mats, which are regarded as safe by the FDA, with good
mechanical properties [20,21]. However, slow degradation
and poor hydrophilicity are problems for PCL applications
in tissue engineering [22]. Therefore, a large number of
PCL-based composite meshes, particularly PCL/gelatin
(PCL/GT) composite membranes, were developed to
improve the adaptability of these meshes [23,24].
PCL/GT mesh is typically obtained by co-spinning solu-
tions of PCL and gelatin in expensive fluoro-substituted
solvents [25,26]. Here, we used twin-nozzle electrospin-
ning to spin the PCL and gelatin solutions in normal or-
ganic solvents to fabricate PCL/gelatin composite meshes.
We then investigated the benefits of USCs in combination
with PCL/GT nanofibrous membranes for wound healing
in a rabbit full-thickness skin excision wound model.
Finally, we tested the effects of USCs condition medium
on proliferation, migration, and tube formation of
HUVECs.Materials and methods
Isolation and purification of USCs
This study was performed in accordance with the princi-
ples of the Helsinki Declaration and was approved by
the Ethical Review Board of Shanghai Six People’s Hos-
pital Affiliated with Jiaotong University. Human urine
samples were obtained from eight healthy men with a
mean age of 25 years (age range 20–28 years). Written in-
formed consent was obtained from all study participants.
To isolate USCs, penicillin and streptomycin were
added to the fresh urine samples (200 ml) at the recom-
mended concentrations to minimize contamination. After
the urine sample was centrifuged for 10 minutes at 400 × g
and room temperature, the supernatant was discarded and
the sediment was washed twice with phosphate-buffered
saline (PBS). The resulting sediment was re-suspended in
Dulbecco’s Modified Eagle Medium (DMEM) supple-
mented with 2% (vol/vol) fetal bovine serum (FBS)
(Gibco, USA), 10 ng/ml of human epidermal growth
factor (hEGF), 2 ng/ml of platelet-derived growth fac-
tor (PDGF), 1 ng/ml of transforming growth factor-β
(TGF-β), 2 ng/ml of basic fibroblast growth factor
(bFGF), 0.5 μM hydrocortisone, 25 μg/ml of insulin,
20 μg/ml of transferrin, 549 ng/ml of epinephrine,
50 ng/ml of triiodothyronine (T3), L-glu and antibiotics.
The cell suspension was plated into gelatin-coated 24-well
plates and incubated at 37°C in a humidified atmosphere
with 5% CO2. The medium was changed after 7 days, and
the non-adherent cells were removed by thoroughly wash-
ing with PBS. Colonies derived from single cells were
marked. The culture medium was refreshed twice per
week. The cells were passaged using 0.25% trypsin when
they reached approximately 80% confluence.
Multipotent differentiation potential of USCs
Osteogenic induction
Cultured USCs at passage 4 were grown to 80% conflu-
ence and subsequently incubated with osteogenic induc-
tion medium (Gibco, USA). After 21 days of induction,
the cells were stained with Alizarin Red S to detect the
deposition of calcified matrix.
Adipogenic induction
The cultured USCs were grown to 80% confluence and
incubated with adipogenesis medium (Gibco, USA). The
culture medium was changed every 3 days. After 14 days
of induction, the cells were fixed in 4% paraformalde-
hyde (PFA) for 30 min at RT and stained with Oil Red O
for 10 min.
Chondrogenic induction
Chondrogenic differentiation of USCs was performed
using a pellet culture technique. Briefly, 1 × 106 cells were
pelleted by centrifugation in a 15-ml centrifuge tube.
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the pellet. After 4 weeks of induction, the pellets were
fixed in 4% PFA and embedded in an optimum cutting
temperature (OCT) compound. The 10-μm cryosections
were stained with Toluidine blue. All of the stained
cells were observed under an optical microscope (Leica,
Germany).
Flow cytometry analysis
Passage 4 USCs were incubated with 3% BSA for 30 mi-
nutes to block nonspecific antigens. The cells were then in-
cubated with the following monoclonal antibodies (Becton
Dickinson): CD29-PE, CD146-FITC, CD73-PE, CD90-
FITC, CD34-APC and HLA-DR-PE. The cells were washed
to remove unbound antibody. Surface antigens were ana-
lyzed using a Guava easyCyte™ (Millipore, USA).
Preparation of PCL/GT membranes
PCL/GT membranes were prepared as previously de-
scribed [27]. PCL was dissolved at 10% (wt/vol) in mix-
tures of 7:1 (vol/vol) dichloroform and dimethylbenzene.
Gelatin was dissolved at 20% (wt/vol) in mixtures of 2:1
(vol/vol) formic acid and ethyl acetate. A twin-spinneret
electrospinning technique was employed to produce PCL
and gelatin composite fibers using the parameters de-
scribed below. We dispensed the PCL solution at a flow
rate of 150 μl min−1 and the gelatin solution at a flow rate
of 60 μl min−1 through a 7-gauge stainless steel dispensing
needle that was clamped to +15 kV using a high voltage
generator. The collector was placed 12 cm from the tip of
the needle horizontally and set to 500 r.p.m. After 1.5 mL
of the gelatin solution and 3 mL of the PCL solution
were electrospun simultaneously, the electrospun hy-
brid meshes were removed from the collector and lyophi-
lized (LGJ-10C, Four-Ring Science Instrument Plant
Beijing Co., Beijing, China) for at least 24 h prior to
imaging or use in biological assays.
Characterization of PCL/GT membranes
The morphologies of the electrospun membranes were
observed using a scanning electron microscope (SEM)
(FEIQuanta, 200SEM) at an accelerating voltage of 30 kV.
Each sample was sputter-coated with platinum for ana-
lysis. The FTIR spectra were recorded on an infrared spec-
trometer (IR, Nioclet 5700) at a 4 cm−1 resolution, with 32
scans in the range of 4,000 to 400 cm−1. Hydrophilicity
properties were determined using a contact angle goniom-
eter (KROSSDSA100, Germany) at room temperature
with 2-μL water droplets. The reported contact angle
value represents an average of at least five independent
determinations at different sites.
The scaffolds were cut into small pieces with sizes of
9 cm2. The in vitro degradation experiment was per-
formed in 50 mL of phosphate-buffered saline (PBS)(pH = 7.4) at 37°C for different time intervals. The deg-
radation rate was evaluated using the observed weight
changes before and after immersion, according to equa-
tion (1).
Weight loss %ð Þ ¼ Wd−Wrð Þ=Wd 100% ð1Þ
Wr represents the remaining weight (after drying) of
the membranes after immersion in PBS, and Wd repre-
sents the original weight of the same membranes prior
to immersion.
The mechanical properties of 17.8 mm× 26.6 mm mem-
brane specimens with thicknesses of 220 μm were deter-
mined using a material testing system with electronic data
evaluation (Zwick/Roell, BZ2.5/TS1S, Germany).
Cell morphology, viability and proliferation in PCL/GT
Membranes
Membranes seeded with USCs were rinsed in 0.1 M
phosphate buffer (pH 7.2) and fixed with 2.5% glutaral-
dehyde in 0.1 M phosphate buffer for 2 hours at 4°C. To
prepare for SEM, the samples were dehydrated with
ethanol and subsequently placed in pure tert-butanol for
30 minutes prior to vacuum drying overnight. After
sputter-coating with platinum, the morphologies of the
cells and the scaffold and cell attachment to the PCL/GT
membranes were analyzed using a SEM (FEIQuanta 200).
The viability of the cells on the PCL/GT membranes was
determined using a live/dead cell staining kit (ScienCell,
USA). Green fluorescence, which occurs due to the reac-
tion of calcein with intracellular esterase, indicated live
cells; while red fluorescence occurs due to the binding of
ethidium homodimers to nucleic acids, indicated dead
cells. The USCs were seeded on PCL/GT membranes that
were commensurate with the size of 24-well plates at a
density of 2 × 104 cells/well in 300 μL of medium. The
same amount of culture medium was added to a well con-
taining a PCL/GT membrane to serve as a control.
Cell proliferation was assessed using a Cell Count-8
kit (CCK-8) (Dojindo Molecular Technologies, Inc.,
Kumamoto, Japan) according to the manufacturer’s
protocol. The plates were then evaluated at 450 nm
using an enzyme-linked immunosorbent assay instru-
ment. The optical density values were calculated from
triplicate samples of each group, and the experiment
was repeated four times.
USCs for skin tissue engineering in rabbits
All in vivo experimental procedures were approved by
the Animal Research Committees of Shanghai Six Peo-
ple’s Hospital. The rabbits were housed individually in
standard cages in a room with controlled temperature
and light in the Facility of the Animal Research Centre
at Shanghai Six People’s Hospital. Nine male New Zealand
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ation of USCs in combination with PCL/GT membranes
and injected with the immunosuppressant cyclosporine A
at a dose of 5 mg/kg per day. The full-thickness skin exci-
sion wound animal model was established as previously
described [28]. On each rabbit, a total of four full-
thickness skin wounds (2 cm × 2 cm) were made dor-
sally, with two wounds on each side of the paravertebra.
The rabbits were treated with PCL/GT membranes or
USCs-PCL/GT membranes, with an untreated group as a
control. All animals were healthy after surgery without
weight loss and were alive at the end of the experimental
period. The adhesive was tested on the skin of rabbits
prior to this experiment, and no skin irritation or allergic
reaction was observed. The animals were killed 7 or
14 days after surgery. The wound area and the surround-
ing outer skin were collected for histological examination.
Wound analysis
Digital photographs of the wounds were taken on day 14
after surgery. The time to wound closure was defined as
the time at which the wound bed was completely re-
epithelialized and filled with new tissue. For whole skin
mounts, the entire wound and the surrounding skin
were placed on a plastic dish with the dermis side down
and photographed immediately. The wound area was
measured group-blindly by tracing the wound margin
and calculated using the Image-Pro Plus 6 program
(Media Cybernetics, Rockville, MD). The percentage of
wound closure was calculated as follows: [(Area of ori-
ginal wound - Area of actual wound)/Area of original
wound] × 100%.
Histologic and immunocytochemical analysis
The tissue specimens were fixed in 4% PFA for 24 hours
and embedded in OCT (ThermoFisher, Waltham, MA).
Six-micron sections were stained with hematoxylin and
eosin (H&E). Histological evaluation was performed based
on previous reports[29,30], including re-epithelialization
and regeneration, collagen formation, and angiogenesis.
Masson’s trichrome staining was employed to visualize
collagen fibers. All sections were analyzed by two patholo-
gists in a blinded manner using light microscopy (Leica).
For immunofluorescence, the tissue sections were pre-
incubated with sodium borohydride (1 mg/ml in PBS) to
reduce autofluorescence. The area of the epidermis was
measured by staining keratinocytes with an antibody
against epidermal pan-cytokeratin (Abcam, 1:100). After
immunofluorescent staining of endothelial cells with an
anti-CD31 antibody (Abcam, 1:50), the microvessel dens-
ity was assessed morphometrically by examining three
fields per wound section [31,32]. A secondary IgG anti-
body conjugated to Alexa Fluor 594 (Jackson, 1:200)
was used for visualization. The nucleus was stainedwith 4′, 6-diamidino-2-phenylindole (DAPI). Isotype con-
trol antibodies were used as negative controls. All stained
cells were observed under a fluorescence microscope
(Leica).
The percentages of keratinocytes and collagen areas
were determined by counting in five random fields per
section between wound edges using Image-Pro Plus 6.
Enzyme-linked immunosorbent assay
To measure angiogenic trophic factors secreted by the
USCs, 1 × 105 USCs at passage 4 were seeded in 6-well
plates and incubated with serum-free DMEM under nor-
mal conditions (i.e., 5% CO2 and 37°C). The culture
medium of the USCs was replaced every 2 days, and the
culture supernatant was aspirated after 48 h for the
measurement of VEGF and TGF-β1 using an enzyme-
linked immunosorbent assay (ELISA) according to the
manufacturer’s instructions (R&D, Systems, USA).
Endothelial cell migration and proliferation assay
RTCA (real-time cell analyzer) migration assays meas-
ure the effects of perturbations in a label-free, real-
time setting. As cells migrate from the coated upper
chamber through the membrane and into the bottom
chamber in response to a chemo-attractant, they con-
tact and adhere to the electronic sensors on the under-
side of the membrane, resulting in an increase in the
electrical impedance. Increasing impedance correlates
with increasing numbers of migrated cells on the
membrane [33].
HUVECs were obtained from ScienCell (Carlsbad, CA,
USA). The cells were cultured in Medium M200 using
low serum growth supplementation (LSGS) kits (Cascade
Biologics, USA) at 37°C in a humidified 5% CO2 atmos-
phere. HUVECs were used at passage number 4 in this
study. For RTCA migration assays, 4 × 104 HUVECs were
seeded into the upper well of each transwell chamber
(8 μm pore size). To observe the effects of USCs-
conditioned medium (i.e., culture supernatant of USCs
after 3 days) on the migration of HUVECs,M200 medium
containing 25% USCs-conditioned medium or USCs-
medium was tested to determine the optimal concen-
tration. USCs-CM (i.e., M200 medium containing 25%
USCs-conditioned medium), USCs-M (i.e., USCs-medium),
and Ctrl (i.e., M200 medium) (300 μl) containing 5% FBS
were placed in the lower compartment of the chemotaxis
chamber as a source of chemo-attractants. The cells were
incubated for 16 h at 37°C in a 5% CO2 atmosphere.
Cells that had migrated to the lower surface of the
membrane were measured using an RTCA analyzer
system (Roche, USA).
A wound healing assay was performed as a supple-
ment to migration ability. Briefly, 2 × 105 cells were
plated in 12-well plates and grown to confluence. Two
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pipette tip, and the scratch width was measured as the
baseline [34]. The wound width was measured using
Image J software (National Institutes of Health, Bethesda,
MD) by mimicking an exclusion zone assay. USCs-M and
USCs-CM were added for 24 h. The width of the scratches
was visualized using a microscope (Leica, Germany).
Proliferation was evaluated using a CCK-8 kit (Dojindo,
Japan) according to the manufacturer’s instructions.
Briefly, HUVECs were seeded into 96-well plates in
100 μl of culture medium (i.e., Ctrl, USCs-M or USCs-
CM) at a density of 5,000 cells per well. After 24, 48,
72, and 96 h, 10 μl of CCK-8 solution were added to
each well and the plates were incubated at 37°C for
3 h. At the end of the incubation, the absorbance at
450 nm was measured using a microplate reader (Bio-Rad
Laboratories Co. USA). All experiments were performed
in triplicate and repeated at least 3 independent times.Endothelial cell network formation assay
Human umbilical vein endothelial cells (HUVECs) (2 × 104
cells per well) were suspended in 100 μl of USCs-M or
USCs-CM and seeded onto Matrigel (BD Biosciences,
USA)-coated 96-well plates. After incubation at 37°C
with 5% CO2 for 6 hours, images were captured. Four
random fields were evaluated for each well.Statistical analysis
The data are expressed as the mean ± SD. Intergroup
comparisons were performed using ANOVA followed by
Tukey post hoc analysis. All data analysis was performed
using SPSS 17.0 (SPSS Inc., Chicago, IL, USA). P values
less than 0.05 (p < 0.05) were considered statistically
significant.Results
Characterization of USCs
Cell colonies were observed in the USCs cultured plates
approximately 8 to 12 days after initial plating. Most of
the adherent cells exhibited a fibroblast-like morphology
(Figure 1A). After 16 days, the fibroblast-like cells retained
a robust proliferation capability and reached 80%-90%
confluence (Figure 1A). No microorganism contamination
was observed in any of the culture plates. When cultured
in osteogenic, adipogenic, or chondrogenic medium, the
USCs differentiated into osteoblasts (Figure 1B:d), adipo-
cytes (Figure 1B:e), or chondrocytes (Figure 1B:f ), re-
spectively. Flow cytometry analyses demonstrated that
the USCs were positive for CD29, CD73, CD146 and
CD90 antigen and negative for CD34 and HLA-DR
(Figure 1C). Thus, the characterization of USCs meets
the criteria for defining multipotent MSCs [35].Characterization of the PCL/GT membranes
Figure 2A (a,b) shows the morphology of the electro-
spun PCL and PCL/GT composite fibrous membranes.
The morphologies of PCL/GT (Figure 2A:b) and PCL
(Figure 2A:a) exhibited randomly oriented non-woven fi-
bers with an open porosity and interconnected pores.
No differences in average fiber size, the distribution of
fiber sizes or pore size were observed between the PCL-
GT fibrous mesh and the PCL membranes. Figure 2C
shows the infrared spectra of the PCL and PCL/GT
composite membranes. The strong absorption band of
the PCL/GT mesh at 3,400–3,500 cm−1 can be attrib-
uted to the overlapping N–H and O–H stretching vibra-
tions of GT. The absorption of the N–H deformation at
1,600–1,650 cm− 1 and 1,500–1,550 cm−1 are also assigned
to GT. The absorption peak at 1,700–1,760 cm−1 occurs
due to C =O groups. For PCL membranes, all of the ob-
served absorption bands resulted from the chemical struc-
ture of PCL.
Contact angles of water droplets have been used to
evaluate the wettability of proposed membranes. As shown
in Figure 2B, the PCL membranes exhibited hydrophobic
characteristics, with water contact values higher than 90°.
However, after the codeposition of GT nanofibers, the
static contact angle of the composite mesh decreased to
nearly 0 from the value observed for the PCL membranes
(109 ± 0.4)due to the existence of a large number of polar
groups along the GT molecular chains.
As shown in Figure 2D, the PCL/GT membranes lost ∼
50% of their initial weight after 1 week of degradation in
PBS. Moreover, this weight loss increased sharply after
6 weeks. The observed 50% loss of the composite scaf-
fold weight results completely from the dissolution of
the GT component in the PCL/GT mesh. This result
suggests that GT could promote the degradation of PCL.
The mechanical strength of scaffolds is an important
factor that must be considered in the context of applica-
tions in skin tissue engineering. The typical strain–stress
curves of the two types of scaffolds are presented in
Figure 2E. The Young’s moduli of the PCL scaffolds
and the PCL/GT scaffolds are 1.43 MPa and 0.86 MPa,
respectively. The Young’s moduli of the volar forearm,
the dorsal forearm, and the palm are 101.180, 68.678,
and 24.910 kPa, respectively [36]. This result demon-
strates that the mechanical properties of PCL/GT fi-
brous membranes are comparable to those of human
skin tissue.
Biocompatibility of PCL/GT membranes in vitro
The USCs were seeded onto PCL/GT membranes.
After seeding the cells onto PCL/GT, the USCs ad-
hered to and spread on the membrane 1 day after seeding.
SEM analyses revealed that the cells proliferated con-
tinuously on the membrane and reached approximately
Figure 1 The characteristics of USCs. A. The morphology and growth of USCs; B. Differentiation of USCs into osteoblasts (d), adipocytes
(e), and chondrocytes (f); C. USCs were characterized by flow cytometry using the surface markers CD29, CD73, CD90, CD146, CD34 and
HLA-DR. Scale bar = 200 μm.
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Figure 2 The characteristics of PCL/GT. SEM images of electrospun PCL/GT (A: a) and PCL (A: b) membranes; (B) images of water droplets on
PCL and PCL/GT scaffolds; (C) FTIR spectra of electrospun membranes; (D) Degradation behavior of PCL/GT composite mesh; (E) Stress–strain
curves of the fibrous membranes. Scale bar = 5 μm.
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Seven days after the USCs were seeded onto PCL/GT
membranes, a live/dead assay demonstrated that the
USCs seeded in the 3D PCL/GT membranes were still
alive (Figure 3B). These results were confirmed using
CCK-8 analysis. Increases in optical density were ob-
served with increasing culture time (Figure 3C). These
data demonstrated that PCL/GT membranes possess
good biocompatibility.
Gross observation of wounds
All wounds were examined and recorded on days 7 and
14 post-surgery. After 7 days, all cotton dressings wereremoved. All wounds in the PCL/GT membrane-treated
groups were moist. However, the wounds of the control
groups were dry. These results demonstrate that the
scaffolds (i.e., the PCL/GT membranes and the USCs-
PCL/GT membranes) are able to keep wounds moist. By
day 14, wound healing was observed in all groups, in-
cluding the treatment groups and the control groups
(Figure 4A). The wounds treated with USCs-PCL/GT
exhibited significantly improved wound contraction. On
day 21, the wounds of all groups were nearly completely
epithelialized. The wounds that received USCs- PCL/GT
closed faster than those that received PCL/GT or remained
untreated (Figure 4B).
Figure 3 The biocompatibility of PCL/GT membranes. A. SEM images of USCs on PCL/GT on day 7, a: low magnification, b: high
magnification; B. The viability of USCs, as analyzed using a live/dead assay in which calcein green indicates live cells; C. USCs showed robust
proliferation on PCL/GT. Scale bar A (a) = 500 μm; A (b) = 50 μm; B = 100 μm.
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A histological evaluation of the rabbit wounds after
14 days revealed enhanced re-epithelialization in the
USCs-PCL/GT treated wounds compared to the PCL/
GT-treated wounds or the untreated wounds (Figure 5A).
The granulation tissue in the USCs-PCL/GT-treated
wounds appeared to be thicker and larger than that of
the PCL/GT-treated wounds or the untreated wounds
(Figure 5A). After 14 days, the collagen content was sig-
nificantly higher in the USCs-PCL/GT group than in the
control and PCL-GT groups (Figure 5B, C). Moreover,
collagen was well organized and skin appendages, such
as hair follicles and sebaceous glands, were found in the
USCs-PCL/GT-treated wounds. Additionally, immuno-
histological staining of tissue sections for cytokeratin
demonstrated that USCs-PCL/GT-treated wounds
were better epithelialized than those of the other groups
(Figure 6A, C).
USCs -PCL/GT membranes enhance angiogenesis in the
wound tissue
Immunohistological staining of tissue sections for the
endothelial marker CD31 (Figure 6B) revealed increased
microvessel density in USCs-PCL/GT-treated woundsafter 7 and 14 days compared to control or PCL/GT-
treated wounds. The microvessel density in the wounds
on day 14 was assessed morphometrically after immuno-
histochemical staining for CD31. The microvessel dens-
ity was significantly higher in USCs-PCL/GT-treated
wounds than in control or PCL/GT-treated wounds
(Figure 6B, D).
USCs secrete angiogenic trophic factors and promote the
proliferation, migration, and tube formation of HUVECs
To further delineate the mechanisms which angiogenesis
is increased by USCs, the VEGF and TGF-β1 levels in
the USCs culture supernatants were tested and found
to be significantly higher than those of the controls
(Figure 7A, B). We further observed the effects of USCs-
conditioned medium (USCs-CM) on the proliferation,
migration, and tube formation of human umbilical
vein endothelial cells. USCs-CM significantly increased
HUVEC proliferation compared to the controls (P < 0.05)
(Figure 7D). The results of RTCA experiments demon-
strated that USCs-CM significantly enhanced the motility
of HUVECs (P < 0.01) (Figure 7C); this finding was con-
firmed by the results of scratch experiments. At 24 h after
scratch initiation, USCs-CM-treated HUVECs covered
Figure 4 The wound areas were analyzed on day 0 and day 14 post-surgery in the control, PCL/GT, and USCs-PCL/GT groups. (A) Gross
appearances of wounds on day 0 and day 14. (B) Significantly faster wound closure was observed in the USCs-PCL/GT group (*P < 0.05 compared
to the PCL/GT group or the Ctrl group).
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cant empty space in the scratch (P <0.05) (Figure 7E, F).
After 6 h of culture on Matrigel, no tube was formed by
USCs-M, while USCs-CM-cultured HUVECs formed many
tubes with obvious structures (Figure 7G), indicating that
paracrine factors in the USCs culture supernatant pro-
moted angiogenesis.
Discussion
The therapeutic approaches for extensive full-thickness
skin defects that result from injuries, burns, other types
of trauma, and non-healing ulcers remain very limited
[37,38]; thus, innovative strategies for improving wound
healing and regeneration are needed. Recently, tissue en-
gineering skin has become a potential strategy for improv-
ing wound healing. In the present study, we demonstrated
for the first time that the transplantation of biomaterials
engineered by incorporating USCs into PCL/GT nanofi-
brous membranes enhanced wound healing in a rabbitfull-thickness skin wound model. In addition, the ob-
served protective effect was likely mediated by USCs
via a paracrine mechanism that affects angiogenesis, as
we found that USCs-conditioned medium could en-
hance endothelial cell migration, proliferation and tube
formation.
Bone marrow-derived mesenchymal stem cells (BMSCs)
promote angiogenesis and improve cutaneous wound
healing [39,40]. However, the source of BMSCs is lim-
ited and the procedure for the isolation of these cells is
invasive. Recently, USCs that can be harvested from
voided urine via a non-invasive procedure have been
reported to possess a high proliferative capacity and
characteristics of stem cells and to exhibit potential for
use in urinary tissue engineering [12,41,42]. Our previ-
ous study also found that USCs have multilineage differ-
entiation potential and possess biological characteristics
similar to ASCs [14]. Moreover, we found that USCs can
differentiate into neuron-like cells in the rat brain,
Figure 5 Histological analysis of rabbit wounds on day 14. (A) Wound histological images (H&E stain); (B) Masson’s trichrome staining, the
bottom shows an enlarged view of the region inside the box; (C) Areas of collagen were quantified in day 14 wounds (Image Pro Plus 6). Significantly
greater collagen area was observed in the USCs-PCL/GT group than in the control or PCL/GT groups (***P < 0.01). Scale bar A = 200 μm, B = 100 μm.
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tissue engineering and regenerative medicine [14]. The
present data further demonstrated that USCs are bene-
ficial for angiogenesis and can be used in skin tissue
engineering.As pre-clinical research investigating the cutaneous
wound healing benefits of MSCs becomes more com-
mon, the majority of studies have investigated the direct
injection of cell suspensions around the wound. Cells
injected directly into the body undergo cell death rapidly
Figure 6 Tissue sections were immunostained with anti-pan-cytokeratin (A) and anti-CD31 antibodies (B). Nuclei (blue) were stained with
DAPI. (C) Significantly greater cytokeratin area was observed in the USCs-PCL/GT group (***P < 0.01 compared to the control group, *P < 0.05
compared to the PCL/GT group). (D) Significantly increased microvessel density was observed in the USCs-PCL/GT group (***P < 0.01 compared
to the control and PCL/GT groups). Scale bar = 100 μm.
Fu et al. Journal of Translational Medicine 2014, 12:274 Page 11 of 14
http://www.translational-medicine.com/content/12/1/274[43]. Biomaterials may support cell viability and enhance
therapeutic efficacy. PCL is a polyester that is widely
used as a tissue engineering scaffold material due to its
well-documented biocompatibility. However, the fact
that PCL degrades much slower than other known bio-
degradable polymers limits the application of this poly-
mer in vivo. The complete biodegradation of PCL in vivo
typically takes more than 1 year due to the hydrophobicity
and crystallinity of this polymer. In addition, for in vivo
applications, biomaterials should be hydrophilic for im-
proved biocompatibility; however, the hydrophilicity of
PCL is very limited. In the present study, we used twin-
nozzle electrospinning of PCL and gelatin solutions in
normal organic solvents to fabricate PCL/gelatin compos-
ite meshes. The results demonstrate that the weight loss
of the PCL/GT mesh may be attributed to the localenvironment of GT degradation, which favors the deg-
radation of the PCL component. Importantly, this re-
sult may offer a new solution to the slow degradation
of PCL in vivo. These results also demonstrate that the
introduction of gelatin greatly improves the hydrophil-
icity and mechanical properties of PCL/GT fibrous
membranes, achieving values comparable to those of
human skin tissue. Together, our results demonstrate
that PCL/GT nanofibrous membranes exhibit good
biocompatibility and sufficient mechanical strength and
can sustain cellular viability. These membranes can also
provide an extracellular matrix (ECM) for wounds to pro-
mote cellular adhesion and proliferation, making them
suitable scaffolds for skin engineering.
Neovascularization is a crucial step in the wound heal-
ing process [38,44]. The formation of new blood vessels
Figure 7 The ELISA assay for USCs-CM and the effect of USCs-CM on HUVECs. The concentration of VEGF (A) and TGF-β (B) in USCs-M and
USCs-CM was measured by ELISA. (C) Real-Time Cell Analyzer showed USCs-CM significantly enhanced the migration of HUVECs. (D) CCK-8 assay
showed USCs-CM significantly promoted HUVECs proliferation after 96 h incubation. (E and F) The scratch experiments demonstrated that
USCs-CM increased the motility of HUVECs. (G) Large numbers of tube were formed in USCs-CM-cultured HUVECs, while no tube was formed in
USCs-M-cultured HUVECs. *** P < 0.01 compared to the control or USCs-M groups at 16 h; *P < 0.05 compared to USCs-M groups. Scale bar = 250 μm.
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sue and promote the survival of keratinocytes. Our data
demonstrated that USCs-PCL/GT-treated wounds increasedthe capillary density on days 7 and day 14, suggesting that
USCs promoted angiogenesis. Paracrine factors from BM-
MSCs have been reported to recruit macrophages and
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healing [45]. The present study represents the first report
that USCs can secrete angiogenic trophic factors, including
VEGF and TGF-β1, and that USCs-conditioned medium
can significantly promote endothelial tube formation and
endothelial cell migration and proliferation, indicating that
paracrine factors released by USCs play a key role in angio-
genesis by stimulating endothelial cell proliferation, migra-
tion and organization into tubules.
Cyclosporin A is widely used in organ and tissue
transplantation to prevent the immune rejection. It’s has
demonstrated that Cyclosporin A improve the survival
rate of graft cells [46]. In this study, consistent with prior
reports, the risk of immune rejection was significantly
lower with the use of Cyclosporin A. To examine whether
Cyclosporin had a side effect on skin wound healing, we
injected Cyclosporin A in some rabbits in the Control
groups. The results showed there is no difference in
wound healing between the injected and un-injected rab-
bits, which confirmed the application of Cyclosporin A
had no side effect on wound healing.
Conclusion
This study reported the beneficial effect of USCs on cu-
taneous regeneration and wound healing via systemic
paracrine effects that promote angiogenesis. We believe
that USCs in combination with PCL/GT nanofibrous
membranes represent a novel therapeutic approach to
the treatment of skin defects.
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